SWILEM PHARMACEUTICALS: what changed
SWILEM PHARMACEUTICALS
Largest movements
- Cash +€8,250
up €8,250 (+74.7%), from €11,045 to €19,294
mainly Depreciation (+€23,404) and Other debts (+€18,458)
- Other debts +€18,458
up €18,458 (+99.5%), from €18,550 to €37,008
- Trade debts +€9,146
up €9,146 (+156%), from €5,872 to €15,018
- Profit (loss) carried forward -€7,783
down €7,783 (-38.6%), from -€20,156 to -€27,940
- Debts after one year -€6,243
down €6,243 (-2.6%), from €242,506 to €236,263
of which Financial debts: -€6,243
- Other operating charges -€7,724
down €7,724 (-62.1%), from €12,435 to €4,712
- Write-downs +€5,534
no longer reported in 2025 (was -€5,534)
- Gross operating margin -€1,683
down €1,683 (-5.3%), from €31,846 to €30,164
- Depreciation +€803
up €803 (+3.6%), from €22,602 to €23,404
- Financial charges -€665
down €665 (-6.4%), from €10,335 to €9,670
Change in the result, 2024 to 2025
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Derived cash bridge
The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €279,816 | €292,979 | +€13,164 | +4.7% |
| Fixed assets | 21/28 | €259,238 | €261,703 | +€2,465 | +1.0% |
| Tangible fixed assets | 22/27 | €258,977 | €261,441 | +€2,465 | +1.0% |
| Land and buildings | 22 | €119,342 | €121,678 | +€2,336 | +2.0% |
| Furniture and vehicles | 24 | €1,325 | €19,912 | +€18,586 | +1,402% |
| Other tangible fixed assets | 26 | €138,310 | €119,852 | -€18,458 | -13.3% |
| Financial fixed assets | 28 | €262 | €262 | = | 0.0% |
| Current assets | 29/58 | €20,577 | €31,276 | +€10,699 | +52.0% |
| Amounts receivable within one year | 40/41 | €8,648 | €9,118 | +€470 | +5.4% |
| Trade receivables | 40 | €8,648 | €9,118 | +€470 | +5.4% |
| Cash at bank and in hand | 54/58 | €11,045 | €19,294 | +€8,250 | +74.7% |
| Deferred charges and accrued income | 490/1 | €885 | €2,864 | +€1,979 | +224% |
| Total equity and liabilities | 10/49 | €279,816 | €292,979 | +€13,164 | +4.7% |
| Equity | 10/15 | -€12,615 | -€20,398 | -€7,783 | -61.7% |
| Contributions | 10/11 | €6,200 | €6,200 | = | 0.0% |
| Reserves | 13 | €1,341 | €1,341 | = | 0.0% |
| Non-distributable reserves | 130/1 | €1,341 | €1,341 | = | 0.0% |
| Reserves not available under the articles | 1311 | €1,341 | €1,341 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€20,156 | -€27,940 | -€7,783 | -38.6% |
| Amounts payable | 17/49 | €292,431 | €313,378 | +€20,947 | +7.2% |
| Amounts payable after more than one year | 17 | €242,506 | €236,263 | -€6,243 | -2.6% |
| Financial debts | 170/4 | €241,556 | €235,313 | -€6,243 | -2.6% |
| Other amounts payable | 178/9 | €950 | €950 | = | 0.0% |
| Amounts payable within one year | 42/48 | €49,925 | €77,115 | +€27,190 | +54.5% |
| Current portion of amounts payable after more than one year | 42 | €20,618 | €23,123 | +€2,505 | +12.2% |
| Trade debts | 44 | €5,872 | €15,018 | +€9,146 | +156% |
| Suppliers | 440/4 | €5,872 | €15,018 | +€9,146 | +156% |
| Taxes, remuneration and social security | 45 | €4,884 | €1,965 | -€2,919 | -59.8% |
| Taxes | 450/3 | €4,884 | €1,965 | -€2,919 | -59.8% |
| Other amounts payable | 47/48 | €18,550 | €37,008 | +€18,458 | +99.5% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €22,602 | €23,404 | +€803 | +3.6% |
| Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) | 631/4 | -€5,534 | - | +€5,534 | |
| Other operating charges | 640/8 | €12,435 | €4,712 | -€7,724 | -62.1% |
| Gross operating margin | 9900 | €31,846 | €30,164 | -€1,683 | -5.3% |
| Operating profit (loss) | 9901 | €2,344 | €2,048 | -€296 | -12.6% |
| Financial income | 75/76B | €25 | - | -€25 | |
| Recurring financial income | 75 | €25 | - | -€25 | |
| Financial charges | 65/66B | €10,335 | €9,670 | -€665 | -6.4% |
| Recurring financial charges | 65 | €10,335 | €9,670 | -€665 | -6.4% |
| Profit (loss) for the period before taxes | 9903 | -€7,966 | -€7,623 | +€344 | +4.3% |
| Income taxes | 67/77 | €169 | €161 | -€8 | -4.8% |
| Profit (loss) for the period | 9904 | -€8,135 | -€7,783 | +€352 | +4.3% |
| Profit (loss) for the period to be appropriated | 9905 | -€8,135 | -€7,783 | +€352 | +4.3% |
Next steps
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 2 November 2026 via checked.be.